newsWHO publishes recommendations on human genome editing13 July 2021 | By Hannah Balfour (European Pharmaceutical Review)To promote the safe and ethical use of genome editing for the treatment of disease and genetic disorders WHO has published the first global recommendations.
newsCRISPR therapies could be one of the most transformative in human history, says GlobalData16 March 2021 | By Hannah Balfour (European Pharmaceutical Review)Adam Pearson, Senior Oncology Analyst at GlobalData, comments on the development of CRISPR-based therapies and outlines potential opportunities and challenges in the space.
newsEMA recommends marketing authorisation to Tegsedi for hereditary transthyretin amyloidosis7 June 2018 | By European Pharmaceutical ReviewThe EMA has recommended granting a marketing authorisation for Tegsedi, a medicine for the treatment of stage 1 or stage 2 polyneuropathy...